Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You ...

Federal regulators are trying to make it easier to develop cheaper alternatives to powerful drugs that many Americans depend on to treat autoimmune diseases or cancers.

In recent weeks, the allergy therapeutics-focused biotech announced it raised the funds from Samsara ... next-generation ...

Experts warn that biodegradable waste like food scraps contribute significantly to landfill methane emissions (GHGs) and ...

Behind them is a slate of drugmakers – from biotech upstarts to pharma giants – racing to ... co-secreted with insulin in the pancreas to suppress appetite and reduce food intake. Several drugmakers, ...